Abstract
In order to evaluate the efficacy of macrolides in pediatric patients with recurrent respiratory tract infections (RRTIs), we enrolled 1,706 children (783 females) aged between 6 months and 14 years (median: 4 years) with an acute respiratory infection and a history of RRTIs (≥8 episodes per year if aged
Original language | English |
---|---|
Pages (from-to) | 53-59 |
Number of pages | 7 |
Journal | Journal of Chemotherapy |
Volume | 15 |
Issue number | 1 |
Publication status | Published - Feb 2003 |
Keywords
- Antibacterials
- Children
- Macrolides
- Pediatric age
- Recurrent respiratory tract infections
ASJC Scopus subject areas
- Pharmacology (medical)
- Microbiology (medical)